派格生物医药-B(02565)完成发行合共513.6万股配售股份

Core Viewpoint - The company, Pagoda Biopharmaceuticals-B (02565), has successfully completed a placement agreement, with all conditions met as of December 22, 2025 [1] Group 1: Placement Details - The joint placement agents sold a total of 5.136 million shares at a price of HKD 58.41 per share [1] - This placement represents approximately 1.81% of the enlarged H-share capital and about 1.31% of the total share capital post-placement [1]